Literature DB >> 6326595

Divergent influences of leukotrienes C4, D4, and E4 on mesenteric and renal blood flow.

B M Chapnick.   

Abstract

Influences of leukotrienes C4 (LTC4), D4 (LTD4), and E4 (LTE4) on mesenteric and renal blood flow were investigated in the anesthetized dog. Blood flow was measured with noncannulating electromagnetic flow probes, and all agonists were injected as a bolus close arterially. When injected into the superior mesenteric artery, LTC4 (0.1-3.0 ng), LTD4 (0.1-1.0 ng), and LTE4 (1-30 ng) produced dose-dependent decreases in blood flow in absence of a change in mean arterial pressure. When compared with intestinal vasoconstrictor responses caused by angiotension II, which was most active, and norepinephrine, which was least active, the leukotrienes were intermediate between these two well-known vasoactive hormones. LTD4 was more active than LTC4, and both were considerably more active than LTE4. In contrast to the intestine, injection of leukotrienes (1,000 ng) into the kidney resulted in little to no change in renal blood flow or mean arterial pressure, but mesenteric flow decreased 10-15 s later. Administration of indomethacin (5 mg/kg iv) did not alter mesenteric vasoconstrictor responses produced by LTD4. However, mesenteric vasoconstrictor responses to prostaglandin (PG)D2 were reduced after indomethacin, whereas renal vasodilation caused by PGD2 was unaffected. These results demonstrate that LTC4, LTD4, and LTE4 differentially affect blood flow in the intestine and kidney and suggest that if circulating levels of leukotrienes are increased, blood flow would be expected to be diverted away from the intestine. These data are thus compatible with the hypothesis that leukotrienes may participate in regulation of peripheral regional blood flow.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6326595     DOI: 10.1152/ajpheart.1984.246.4.H518

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  SK&F S-106203 inhibits leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious rat.

Authors:  E F Smith; M J Slivjak; J W Egan; R D Eckardt; J F Newton
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

2.  Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis.

Authors:  W Hsueh; F Gonzalez-Crussi; J L Arroyave
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

3.  A possible role for leukotrienes in the regulation of glomerular haemodynamics in the dog.

Authors:  J Heller; V Horácek; S Kamarádová
Journal:  Pflugers Arch       Date:  1988-07       Impact factor: 3.657

Review 4.  Cardiovascular effects of leukotrienes.

Authors:  J Fauler; J C Frölich
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

5.  Interdependence of contractile responses of rat small mesenteric arteries on nitric oxide and cyclo-oxygenase and lipoxygenase products of arachidonic acid.

Authors:  X C Wu; E Johns; J Michael; N T Richards
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.